1. Home
  2. ASND vs LSCC Comparison

ASND vs LSCC Comparison

Compare ASND & LSCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASND
  • LSCC
  • Stock Information
  • Founded
  • ASND 2006
  • LSCC 1983
  • Country
  • ASND Denmark
  • LSCC United States
  • Employees
  • ASND N/A
  • LSCC N/A
  • Industry
  • ASND Biotechnology: Pharmaceutical Preparations
  • LSCC Semiconductors
  • Sector
  • ASND Health Care
  • LSCC Technology
  • Exchange
  • ASND Nasdaq
  • LSCC Nasdaq
  • Market Cap
  • ASND 8.8B
  • LSCC 7.3B
  • IPO Year
  • ASND 2015
  • LSCC 1989
  • Fundamental
  • Price
  • ASND $126.66
  • LSCC $50.72
  • Analyst Decision
  • ASND Strong Buy
  • LSCC Strong Buy
  • Analyst Count
  • ASND 13
  • LSCC 12
  • Target Price
  • ASND $195.00
  • LSCC $63.08
  • AVG Volume (30 Days)
  • ASND 537.5K
  • LSCC 2.0M
  • Earning Date
  • ASND 11-05-2024
  • LSCC 11-04-2024
  • Dividend Yield
  • ASND N/A
  • LSCC N/A
  • EPS Growth
  • ASND N/A
  • LSCC N/A
  • EPS
  • ASND N/A
  • LSCC 1.36
  • Revenue
  • ASND $340,327,869.00
  • LSCC $627,656,000.00
  • Revenue This Year
  • ASND $16.12
  • LSCC N/A
  • Revenue Next Year
  • ASND $87.44
  • LSCC $16.47
  • P/E Ratio
  • ASND N/A
  • LSCC $37.20
  • Revenue Growth
  • ASND 166.54
  • LSCC N/A
  • 52 Week Low
  • ASND $85.29
  • LSCC $40.65
  • 52 Week High
  • ASND $161.00
  • LSCC $85.69
  • Technical
  • Relative Strength Index (RSI)
  • ASND 38.86
  • LSCC 49.98
  • Support Level
  • ASND $125.40
  • LSCC $48.23
  • Resistance Level
  • ASND $132.63
  • LSCC $52.86
  • Average True Range (ATR)
  • ASND 4.46
  • LSCC 1.91
  • MACD
  • ASND -1.87
  • LSCC -0.39
  • Stochastic Oscillator
  • ASND 5.19
  • LSCC 44.86

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia.

Share on Social Networks: